An Overfeeding-Induced Obesity Mouse Model Reveals Necessity for Sin3a in Postnatal Peak β-Cell Mass Acquisition.
Alberto BartoloméYann RavussinJunjie YuAnthony W FerranteUtpal B PajvaniPublished in: Diabetes (2022)
The increase of functional β-cell mass is paramount to maintaining glucose homeostasis in the setting of systemic insulin resistance and/or augmented metabolic load. Understanding compensatory mechanisms that allow β-cell mass adaptation may allow for the discovery of therapeutically actionable control nodes. In this study, we report the rapid and robust β-cell hyperplasic effect in a mouse model of overfeeding-induced obesity (OIO) based on direct gastric caloric infusion. By performing RNA sequencing in islets isolated from OIO mice, we identified Sin3a as a novel transcriptional regulator of β-cell mass adaptation. β-Cell-specific Sin3a knockout animals showed profound diabetes due to defective acquisition of postnatal β-cell mass. These findings reveal a novel regulatory pathway in β-cell proliferation and validate OIO as a model for discovery of other mechanistic determinants of β-cell adaptation.
Keyphrases
- single cell
- insulin resistance
- cell therapy
- type diabetes
- mouse model
- high fat diet induced
- small molecule
- cardiovascular disease
- transcription factor
- high throughput
- blood pressure
- gene expression
- body mass index
- lymph node
- radiation therapy
- weight loss
- autism spectrum disorder
- drug induced
- polycystic ovary syndrome